• Immunicum Announces Results of Directed Share Issue firstwordpharma
    June 18, 2021
    Immunicum AB (publ) (Nasdaq Stockholm: IMMU) ("Immunicum" or the "Company") today announces that it has successfully completed a directed share issue of 33,233,433 shares at a subscription price of SEK 4.25 per share (the "Directed Issue")
PharmaSources Customer Service